The association between low HDL cholesterol (HDL-C) concentrations and increased cardiovascular risk is well established. Low HDL-C levels were found in subjects with type 1 diabetes (T1D) who presented complications (1) and in untreated subjects with celiac disease (CD). The association between TID and CD might therefore enhance this lipid abnormality and accelerate the atherosclerotic process.

We collected data from 13 centers belonging to the Italian Society of Pediatric Endocrinology and Diabetology (ISPED) of a large number of children with both T1D and concurrent biopsy-proven CD, at the exact time point a gluten-free diet (GFD) was initiated and after 1 year of a GFD, verified by means of CD-related antibodies. A total of 201 children with T1D diagnosed at age of 5.8 ± 3.8 years and CD diagnosed at age of 7.5 ± 4.5 years were enrolled. We included only the cases in which CD diagnosis was made at least 3 months after that of T1D to avoid a potential influence of the metabolic derangement at diabetes onset. As a control group, we used a group of 224 patients with T1D only, matched by age, sex, diabetes duration, and HbA1c.

Before GFD was initiated, HDL-C values were significantly lower in children with CD and T1D than in the control group, and the greatest decrease was found in younger children aged <6 years (Table 1). The subjects with HDL-C values lower than pediatric percentile cut points for sex and age were younger than those with normal values (6.2 ± 4.4 vs. 8.6 ± 4.3 years, P < 0.0001) and had lower HbA1c (7.5 ± 0.8 vs. 8.0 ± 1.5%, P < 0.005).

Table 1

HDL-C levels (mg/dL) in children with T1D alone and with T1D and CD before and after starting a GFD

Patients with T1D and CD (n = 201)Patients with T1D only (n = 224)
Before GFDPAfter GFD
All cases (n = 201) 51.3 ± 13.6* <0.0001 60.9 ± 13.7 65.1 ± 30.8 
Age <6 years (n = 90) 46.5 ± 13.6* <0.0001 59.2 ± 12.8  
Age >6 years (n = 111) 55.2 ± 12.3 <0.0001 62.4 ± 14.3  
Adherence to GFD diet 
 Poor (n = 33) 51.8 ± 14.1§ NS 56.6 ± 13.5  
 Partial (n = 39) 54.9 ± 12.0§ <0.05 64.2 ± 14.1  
 Complete (n = 129) 50.1 ± 13.8* <0.0001 61.1 ± 13.4  
Patients with T1D and CD (n = 201)Patients with T1D only (n = 224)
Before GFDPAfter GFD
All cases (n = 201) 51.3 ± 13.6* <0.0001 60.9 ± 13.7 65.1 ± 30.8 
Age <6 years (n = 90) 46.5 ± 13.6* <0.0001 59.2 ± 12.8  
Age >6 years (n = 111) 55.2 ± 12.3 <0.0001 62.4 ± 14.3  
Adherence to GFD diet 
 Poor (n = 33) 51.8 ± 14.1§ NS 56.6 ± 13.5  
 Partial (n = 39) 54.9 ± 12.0§ <0.05 64.2 ± 14.1  
 Complete (n = 129) 50.1 ± 13.8* <0.0001 61.1 ± 13.4  

Data are mean ± SD, unless stated otherwise. NS, not significant.

*

P < 0.0001,

P < 0.001,

§

P < 0.05 vs. control subjects.

P < 0.0001 vs. aged >6 years.

After GFD, the mean values of HDL-C in the total study population significantly increased (60.9 ± 13.7 vs. 51.3 ± 13.6 mg/dL, P < 0.0001) and normalized. In children <6 years of age, the increase in HDL-C values was greater than in older children (28 vs. 13%) The percentage of subjects with HDL-C values lower than pediatric percentile cut points fell significantly (P < 0.0001) from 42 to 16%. Subjects with complete adherence to GFD showed the most significant improvement of HDL-C, and subjects with partial adherence showed a lower, but significant, improvement of HDL-C.

Our results confirm other data reported in the past few years (24) but showed a more evident reduction in HDL-C at diagnosis and a greater restore after GFD. This reduction of HDL-C has been interpreted as a proxy marker for intestinal inflammation or as a consequence of altered intestinal secretion of apolipoprotein AI (5), the major HDL structural protein. This occurs most considerably in the youngest children who probably have a more severe disease, as suggested by the presence of signs of malabsorption, e.g., lower HDL-C and HbA1c levels.

An unfavorable lipid profile, i.e., low HDL-C values, characterizes children with T1D and untreated CD, especially the youngest. GFD is able to normalize HDL-C levels and the more marked beneficial effect of gluten withdrawal can be found in individuals who adhere to the GFD and in the youngest individuals. Therefore, a strict GFD is mandatory in these children, as they may be at increased risk of cardiovascular disease.

Duality of Interest. No potential conflicts of interest relevant to this article were reported.

Author Contributions. S.S. conceptualized and designed the study and drafted the initial manuscript. G.M. coordinated and supervised data collection and edited the manuscript. S.Z. contributed to discussion and reviewed the manuscript. D.I. researched published data and participated in study supervision. S.C., A.Z., B.P., M.M., V.C., R.F., I.R., B.P., R.S., A.S., P.R., G.B., V.C., and G.d’A. collected data in each center and reviewed the manuscript. M.Z. contributed to the statistical analysis. S.T. contributed to interpretation of the data and researched the data. All authors approved the final version for submission. S.S. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

1.
Salardi
S
,
Balsamo
C
,
Zucchini
S
, et al
.
High rate of regression from micro-macroalbuminuria to normoalbuminuria in children and adolescents with type 1 diabetes treated or not with enalapril: the influence of HDL cholesterol
.
Diabetes Care
2011
;
34
:
424
429
2.
Leeds
JS
,
Hopper
AD
,
Hadjivassiliou
M
,
Tesfaye
S
,
Sanders
DS
.
High prevalence of microvascular complications in adults with type 1 diabetes and newly diagnosed celiac disease
.
Diabetes Care
2011
;
34
:
2158
2163
3.
Jessup
AB
,
Law
JR
,
Spagnoli
A
.
Are HDL levels lower in children with type 1 diabetes and concurrent celiac disease compared with children with type 1 diabetes only?
J Pediatr Endocrinol Metab
2014
;
27
:
1213
1216
4.
Warncke
K
,
Liptay
S
,
Fröhlih-Reiterer
E
, et al
.
Vascular risk factors in children, adolescents and young adults with type 1 diabetes complicated by celiac disease: results from the DPV initiative
.
Pediatr Diabetes
2016
;
17
:
191
198
5.
Filik
L
,
Malandrino
N
,
Farnetti
S
, et al
.
High-density lipoprotein, apolipoprotein AI concentrations, and celiac disease
.
J Clin Gastroenterol
2010
;
44
:
592
593; author reply 592–593